Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simethicone for post-colonoscopy abdominal distension
ChiCTR2400091746Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of simethicone in abdominal bloating and Abdominal discomfort (3 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Post-colonoscopy bloating, abdominal pain and abdominal discomfort and Duration of postoperative bloating. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
simethicone
03
Conditions
abdominal bloatingAbdominal discomfort
Beyond the preview
Go deeper on ChiCTR2400091746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091746.